AFP
20205 articles published since 08 Mar 2022
20205 articles published since 08 Mar 2022
Amazon's share price skyrocketed by more than ten percent on Thursday after the online retail behemoth reported better than expected earnings, powered by surging demand for its cloud computing services.
Powered by its sovereign wealth fund of nearly $1 trillion, Saudi Arabia is backing its new AI firm Humain, entering a highly competitive sector some fear is a bubble ready to burst.
The head of the UN's flagship climate fund has announced a record-breaking year for approving projects in vulnerable countries, crediting red-tape-cutting reforms for the achievement that includes a major desalination project in Jordan.
Chinese electric vehicle giant BYD said on Thursday its third-quarter profit had slumped by 33 percent year-on-year, with sluggish domestic consumption piling pressure on the carmaker as it looks to expand overseas.
Shares in Stellantis suffered a double-digit fall on Thursday as the US-European auto giant whose brands include Jeep, Fiat and Peugeot warned of financial bumps ahead. But Stellantis also warned it expects to incur charges in the second half of the year.
A US federal data blackout deepened Thursday as a government shutdown halted the release of third quarter GDP figures, forcing policymakers, financial institutions and business owners to continue flying blind.
Struggling Japanese carmaker Nissan said it expected to suffer an operating loss of 275 billion ($1.8 billion) in its fiscal year that ends in March as it faces further economic headwinds. It also said it expected an operating loss of 30 billion yen for the first six months of the fiscal year, which runs through September.
Italy's government said Thursday it would address concerns over a new bridge to Sicily, after Prime Minister Giorgia Meloni condemned a court ruling against the project as an "intolerable intrusion". Meloni, leader of the far-right Brothers of Italy party, condemned Wednesday's ruling as "yet another encroachment on the jurisdiction of the government and parliament".
Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called the move "reckless". Pfizer called Novo Nordisk's offer a "reckless and unprecedented proposal".
AFP
Load more